(Senior) Business Development Manager

Remote

Apply with AI Apply

Not SpecifiedCompensation

Senior (5 to 8 years), Expert & Leadership (9+ years)Experience Level

Full TimeJob Type

UnknownVisa

Biotechnology, Pharmaceuticals, Synthetic BiologyIndustries

Requirements

Candidates should have over 5 years of commercial experience in biotech, CDMO/CRO services, or life sciences tools, with a total of 10 years of experience in the biotech or life sciences industry. A proven track record of selling bespoke technical services, particularly those requiring strategic creativity, is essential. A deep understanding of CMC, process development, and manufacturing of biologics and/or viral vectors is required, along with the ability to manage complex sales cycles and strong internal and external communication and relationship-building skills. A scientific or technical background in life sciences, such as bioengineering, molecular biology, or biochemistry, is preferred, though advanced degrees (MBA, MS, PhD) are not mandatory.

Responsibilities

The Business Development Manager will develop and execute territory growth strategies to increase revenue, expand market presence, and position Asimov within the biopharma ecosystem. This involves identifying, developing, and closing new business opportunities with biopharma companies, owning the commercial deal process, and shaping partnership strategies. The role also includes contributing to a collaborative company culture, representing Asimov at industry events, and sharing insights to support team success.

Skills

Business Development

Sales

Biopharma

Synthetic Biology

Partnership Strategy

Deal Negotiation

Market Expansion

Relationship Building

Strategic Planning

Asimov

Synthetic biology solutions for biopharmaceuticals

About Asimov

Asimov operates in the synthetic biology field, providing a combination of cells, genes, and software to assist in advanced genetic design. Their products include cloud-based software that allows clients in the biopharmaceutical industry to design, simulate, and optimize genetic systems. Additionally, they offer engineered GMP host cells that are used for therapeutic applications. Asimov distinguishes itself from competitors by guaranteeing high titer cell lines for monoclonal antibodies with a promise of '4 g/L or it's free,' which reduces risk for their clients. The company's goal is to enable biopharma companies to produce high-quality protein therapeutics and scalable viral vectors efficiently, supported by their in-house expertise in synthetic biology and process development.

Boston, MassachusettsHeadquarters

2017Year Founded

$199.1MTotal Funding

SERIES_BCompany Stage

AI & Machine Learning, BiotechnologyIndustries

51-200Employees

Risks

Competition from LatchBio's code-free biocomputing infrastructure challenges Asimov's software offerings.

Integration of The Foundry may lead to potential cultural clashes and operational disruptions.

Rapid data generation in synthetic biology may strain Asimov's data processing capabilities.

Differentiation

Asimov offers a '4 g/L or it's free' promise for monoclonal antibodies.

The LV Edge Producer System eliminates GMP plasmid costs and reduces process complexity.

Asimov integrates synthetic biology, computer-aided design, and machine learning for genetic design.

Upsides

Stable cell line development reduces costs and increases scalability in lentiviral production.

Acquisition of The Foundry enhances Asimov's expertise in genetic design and engineering.

Growing biotech investments indicate a robust market for Asimov's engineered cell lines.

Land your dream remote job 3x faster with AI

Try Jobo Free